首頁 > 市場調查報告書 > 製藥

處方藥疼痛

市場調查報告書

商品編碼

1561566

2024-2032 年按治療類別、配方、類型（處方止痛藥、非處方止痛藥）、配銷通路和地區分類的局部止痛市場報告

Topical Pain Relief Market Report by Therapeutic Class, Formulation, Type (Prescription Pain Relief, Over the Counter Pain Relief), Distribution Channel, and Region 2024-2032

出版日期: 2024年09月10日 | 出版商:

IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球局部止痛藥市場規模達105IMARC Group美元。全球市場的主要促進因素包括關節炎和肌肉骨骼疾病盛行率的上升、藥物傳輸技術的不斷進步、消費者對非侵入性和非藥物治療的偏好不斷增加以及研發方面的大量投資。

局部止痛市場分析：

市場成長與規模：在關節炎和肌肉骨骼疾病盛行率不斷上升、藥物傳遞技術的進步以及對非藥物治療的日益偏好等因素的推動下，市場正在經歷強勁成長。市場規模龐大且持續擴大，各種產品滿足處方藥和非處方止痛需求。
主要市場驅動力：關節炎和肌肉骨骼疾病發生率的上升，特別是隨著全球人口老化，是推動止痛產品需求的主要驅動力。藥物輸送系統的技術進步提供了增強的功效和控制釋放，對市場成長做出了重大貢獻。
技術進步：藥物傳輸技術（包括微膠囊化和奈米製劑）的不斷進步正在提高止痛產品的功效和效率。具有增強滲透性和更持久效果的創新配方正在滿足消費者對有效、便利的疼痛管理解決方案的偏好。
產業應用：止痛產品廣泛應用於治療關節炎、肌肉拉傷、扭傷和運動相關傷害等各種疾病。該市場既滿足針對嚴重疼痛的處方治療，也滿足滿足自我管理、輕度緩解疼痛需求的非處方藥選擇。
主要市場趨勢：
消費者對非藥物和非侵入性治療的偏好日益成長是一個突出趨勢，導致人們對止痛產品的接受度提高。產品範圍的擴大包括天然和有機成分，符合整體和以健康為中心的醫療保健趨勢。
地理趨勢：
由於慢性疼痛的高盛行率、完善的醫療基礎設施以及持續的研發計劃，北美在市場上處於領先地位。由於人口眾多、醫療保健意識不斷提高以及可支配收入不斷增加，亞太地區正在經歷快速成長。
競爭格局：
市場主要參與者正在投資研發，以推出創新配方、增強藥物輸送系統並擴大其產品組合。夥伴關係、合作和收購是加強市場地位和利用互補能力的常見策略。
挑戰與機會：
嚴格的監管框架，尤其是處方產品，為產品開發和市場進入帶來了挑戰。機會在於透過持續創新、利用線上分銷管道以及開拓醫療保健需求未滿足的新興市場來滿足消費者的多樣化需求。

局部止痛市場趨勢：

關節炎和肌肉骨骼疾病的盛行率不斷增加

與口服藥物相比，局部止痛產品（例如乳霜、凝膠和貼片）可提供針對性的疼痛緩解，且全身副作用的風險較低。這使得它們對於可能需要處理多種健康問題和藥物的老年患者特別有吸引力。此外，人們越來越認知並接受局部療法作為口服止痛藥的可行替代品，進一步促進了市場的成長。患有骨關節炎和類風濕關節炎等疾病的患者經常發現局部應用可以立即緩解局部疼痛，從而提高他們的生活品質。具有增強滲透性和更持久效果的創新配方的發展也推動了消費者對這些產品的偏好。

藥物傳輸技術的不斷進步

該市場也受到藥物輸送技術不斷進步的推動。創新的遞送系統，包括微膠囊和奈米製劑，顯著提高了止痛產品的功效和效率。這些技術能夠更好地滲經皮膚、控制釋放和靶向輸送活性藥物成分 (API)，從而改善疼痛管理效果。非侵入性給藥方法的發展符合消費者對與傳統口服藥物相比副作用較少、全身暴露較低的治療方法日益成長的偏好。增強的藥物輸送技術也為現有藥物的重新配製提供了機會，有可能透過改善性能和患者依從性來重振舊 API。

增加研發投資（R&D）

製藥公司加大研發投資進一步推動市場發展。這項投資旨在改進現有產品並開發功效更好、作用時間更長、副作用更少的新配方。研發工作也致力於探索具有鎮痛特性的新型活性成分和天然化合物，以滿足消費者對天然和有機產品日益成長的偏好。這些創新提高了產品的有效性，並有助於使產品在競爭激烈的市場中脫穎而出。產品組合的擴展包括一系列活性成分和不同的強度，以滿足不同消費者的需求和偏好。

The global topical pain relief market size reached US$ 10.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 17.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The global market is primarily driven by the rising prevalence of arthritis and musculoskeletal disorders, continual advancements in drug delivery technologies, increasing consumer preference for non-invasive and non-pharmacological treatments, and significant investment in research and development.

Topical Pain Relief Market Analysis:

Market Growth and Size: The market is experiencing robust growth, driven by factors such as the increasing prevalence of arthritis and musculoskeletal disorders, advancements in drug delivery technologies, and the growing preference for non-pharmacological treatments. The market size is substantial and continues to expand, with a diverse range of products catering to both prescription and over-the-counter pain relief needs.
Major Market Drivers: The rising incidence of arthritis and musculoskeletal conditions, particularly with an aging global population, is a major driver propelling the demand for pain relief products. Technological advancements in drug delivery systems, offering enhanced efficacy and controlled release, contribute significantly to market growth.
Technological Advancements: Ongoing advancements in drug delivery technologies, including microencapsulation and nano-formulations, are improving the efficacy and efficiency of pain relief products. Innovative formulations with enhanced penetration and longer-lasting effects are addressing consumer preferences for effective and convenient pain management solutions.
Industry Applications: Pain relief products find extensive applications in treating various conditions such as arthritis, muscle strains, sprains, and sports-related injuries. The market caters to both prescription-based treatments for severe pain conditions and over-the-counter options for self-manageable, milder pain relief needs.
Key Market Trends:
Growing consumer preference for non-pharmacological and non-invasive treatments is a prominent trend, leading to increased acceptance of pain relief products. The expansion of the product range to include natural and organic ingredients aligns with the trend towards holistic and wellness-focused healthcare.
Geographical Trends:
North America leads the market, driven by a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and ongoing research and development initiatives. Asia Pacific is witnessing rapid growth due to a large population, increasing healthcare awareness, and rising disposable incomes.
Competitive Landscape:
Key players in the market are investing in research and development to introduce innovative formulations, enhance drug delivery systems, and expand their product portfolios. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.
Challenges and Opportunities:
Stringent regulatory frameworks, especially for prescription-based products, pose challenges in product development and market entry. Opportunities lie in addressing the diverse needs of consumers through continuous innovation, leveraging online distribution channels, and tapping into emerging markets with unmet healthcare needs.

Topical Pain Relief Market Trends:

Increasing prevalence of arthritis and musculoskeletal disorders

Topical pain relief products, such as creams, gels, and patches, offer targeted pain relief with a lower risk of systemic side effects compared to oral medications. This makes them particularly appealing for elderly patients who may be managing multiple health issues and medications. Moreover, the increasing awareness and acceptance of topical therapies as a viable alternative to oral analgesics further contribute to the market growth. Patients with conditions, such as osteoarthritis and rheumatoid arthritis often find that topical applications provide immediate relief from localized pain, improving their quality of life. The development of innovative formulations with enhanced penetration and longer-lasting effects also drives consumer preference towards these products.

Continual advancements in drug delivery technologies

The market is also driven by continuous advancements in drug delivery technologies. Innovative delivery systems, including microencapsulation and nano-formulations have significantly enhanced the efficacy and efficiency of pain relief products. These technologies enable better skin penetration, controlled release, and targeted delivery of active pharmaceutical ingredients (APIs), leading to improved pain management outcomes. The development of non-invasive delivery methods aligns with the growing consumer preference for treatments with fewer side effects and lower systemic exposure compared to traditional oral medications. Enhanced drug delivery technologies also open up opportunities for the reformulation of existing drugs, potentially revitalizing older APIs with improved performance and patient compliance.

Increased investment in research and development (R&D)

The market is further propelled by increased investment in research and development by pharmaceutical companies. This investment is aimed at improving existing products and developing new formulations with better efficacy, longer duration of action, and fewer side effects. R&D efforts are also focused on exploring novel active ingredients and natural compounds with analgesic properties, catering to the growing consumer preference for natural and organic products. These innovations enhance product effectiveness and aid in differentiating products in a competitive market. The expansion of the product portfolio to include a range of active ingredients and varying strengths caters to diverse consumer needs and preferences.

Topical Pain Relief Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on therapeutic class, formulation, type, and distribution channel.

Breakup by Therapeutic Class:

Non-Opioids
Opioids

Non-opioids accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the therapeutic class. This includes non-opioids and opioids. According to the report, non-opioids represented the largest segment.

The non-opioids segment holds the largest share in the global market, driven by their widespread acceptance and lower risk profile compared to opioids. This segment includes products containing active ingredients such as NSAIDs capsaicin, lidocaine, and salicylates. Non-opioid topical analgesics are favored for their efficacy in treating mild to moderate pain, particularly in conditions, including arthritis, muscle strains, and sprains. Their popularity is further bolstered by the minimal risk of addiction and fewer systemic side effects, making them suitable for a broader range of patients, including the elderly and those with chronic conditions.

On the contrary, the opioids segment, although smaller compared to non-opioids, plays a crucial role in the market, particularly for patients with severe or chronic pain unresponsive to non-opioid treatments. Topical opioids typically include formulations with controlled concentrations of active substances, including morphine, fentanyl, and buprenorphine. The advantage of topical opioids lies in their ability to provide potent pain relief directly at the site of pain with reduced systemic exposure.

Breakup by Formulation:

Cream
Gel
Spray
Patch
Others

Patch holds the largest share in the industry

A detailed breakup and analysis of the market based on the formulation have also been provided in the report. This includes cream, gel, spray, patch, and others. According to the report, patch accounted for the largest market share.

The patch segment dominates the market segmentation based on formulation in the market. Patches offer a convenient and sustained-release delivery system for active pharmaceutical ingredients, ensuring prolonged and controlled pain relief. These patches are applied directly to the skin, providing localized treatment with minimal systemic absorption. The popularity of patches can be attributed to their ease of use and long-lasting effects, making them particularly appealing for patients seeking continuous pain management. The transdermal delivery method minimizes the need for frequent reapplication, enhancing patient compliance. Additionally, patches are available in various strengths, catering to a diverse range of pain intensities and conditions.

On the other hand, creams are well-received for their smooth texture and quick absorption, providing rapid relief to localized areas of pain. This formulation is favored for its ease of application and the ability to cover larger surface areas, making it suitable for conditions such as arthritis and muscle soreness. Creams often contain active ingredients, including NSAIDs, menthol, or camphor, addressing various types of pain.

Furthermore, the gel segment in the global market holds a significant share, driven by its suitability for targeted pain relief and versatility in application. Gels provide a cooling or warming sensation upon application, offering an additional layer of comfort for users. This formulation is popular for its quick absorption and ability to deliver active ingredients directly to the affected area. Gels are commonly used for conditions like arthritis, joint pain, and muscle strains.

Moreover, the spray segment is a dynamic and expanding category in the market, gaining traction for its convenient and precise application. Pain relief sprays are known for their quick and even distribution of active ingredients over the affected area, providing instant relief. This formulation is often preferred for its non-greasy nature and the ability to reach areas that may be challenging to treat with creams or patches.

Breakup by Type:

Prescription Pain Relief
Over the Counter (OTC) Pain Relief

The report has provided a detailed breakup and analysis of the market based on the type. This includes prescription pain relief and over the counter (OTC) pain relief.

Prescription pain relief formulations often contain potent active ingredients and may include opioids or higher concentrations of non-opioid analgesics. These products are typically recommended by healthcare practitioners after a thorough assessment of the patient's medical history and pain severity. The prescription segment adheres to strict regulatory controls and is subject to healthcare provider oversight to ensure appropriate use and minimize the risk of adverse effects. The demand for prescription pain relief is driven by patients with conditions such as post-surgical pain, neuropathic pain, or other complex pain syndromes that may not be effectively managed by over-the-counter alternatives.

On the contrary, over the counter (OTC) pain relief segment constitutes a substantial portion of the pain relief market, appealing to consumers seeking accessible and self-manageable solutions for mild to moderate pain. OTC products are available without the need for a prescription, allowing consumers to make independent choices for their pain management needs.

Breakup by Distribution Channel:

Pharmacy and Drug Stores
Retail Stores
Online Stores

Online stores exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes pharmacy and drug stores, retail stores, and online stores. According to the report, online stores accounted for the largest market share.

The online stores segment stands out as the largest in the market segmentation based on distribution channels for pain relief products. The rise of e-commerce has transformed the way consumers purchase healthcare products, including pain relief solutions. Online stores offer a vast array of choices, allowing consumers to explore different brands, formulations, and customer reviews before making a purchase decision. The convenience of doorstep delivery further enhances the appeal of online channels, particularly for individuals with mobility issues or those seeking a discreet shopping experience. The online segment benefits from the global reach, enabling consumers to access a diverse range of products that may not be available in local stores.

On the other hand, the retail stores segment is another significant distribution channel for pain relief products, encompassing a diverse range of general merchandise and convenience stores. Retail stores offer accessibility to a broad consumer base, making pain relief products readily available during routine shopping trips. These outlets typically stock a variety of over-the-counter pain relief options, appealing to consumers seeking convenience and a quick purchase experience.

Furthermore, the pharmacy and drug stores segment represent a significant portion of the market for pain relief products, offering a traditional and trusted distribution channel for consumers seeking immediate access to pain management solutions. These establishments provide a wide range of over the counter and prescription pain relief products, allowing customers to receive personalized recommendations from pharmacists.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America leads the market, accounting for the largest topical pain relief market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America stands out as the largest segment for pain relief products. The region's dominance is attributed to several factors, including a high prevalence of chronic pain conditions, a well-established healthcare infrastructure, and a strong emphasis on research and development. North America has a substantial aging population, contributing to an increased incidence of musculoskeletal disorders and arthritis, augmenting the demand for effective pain relief solutions. Additionally, the region's proactive approach to healthcare, coupled with a higher awareness of pain management options, supports the robust growth of the topical pain relief market.

On the other hand, the Asia Pacific region is a dynamic and rapidly growing segment in the market for pain relief products. Factors such as a large population, increasing healthcare awareness, and rising disposable incomes contribute to the expanding market in this region. As lifestyles become more sedentary and the aging population grows, there is a rise in the prevalence of chronic conditions, fueling the demand for effective pain management solutions. Moreover, the cultural acceptance of topical therapies, along with the availability of a diverse range of traditional remedies, adds to the market's versatility.

Additionally, Europe represents a significant market segment for pain relief products, characterized by a mature healthcare system, a high prevalence of chronic conditions, and a strong emphasis on wellness. The region's aging population contributes to the demand for pain management solutions, particularly for conditions, including osteoarthritis and rheumatoid arthritis. European consumers are increasingly inclined towards non-pharmacological and non-invasive pain relief options, aligning with the global trend.

Moreover, Latin America emerges as a significant and growing market segment for pain relief products, driven by factors such as a rising middle class, increasing healthcare awareness, and a growing aging population. The region experiences a considerable burden of musculoskeletal disorders and sports-related injuries, propelling the demand for effective pain relief solutions.

Furthermore, the Middle East and Africa represent a developing market segment for pain relief products. The region's market is influenced by factors such as a growing population, improving healthcare infrastructure, and an increasing awareness of pain management options. Chronic conditions, including musculoskeletal disorders, are on the rise, contributing to the demand for pain relief solutions.

Leading Key Players in the Topical Pain Relief Industry:

Key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. This includes investments in research and development to introduce innovative formulations, enhanced drug delivery systems, and novel active ingredients. Companies are focusing on expanding their product portfolios to address a wide range of pain conditions and consumer preferences. Additionally, marketing efforts emphasize the efficacy and safety of their products, targeting both healthcare professionals and informed consumers. Partnerships, collaborations, and acquisitions are common strategies to strengthen market positions and leverage complementary capabilities.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Advacare Pharma
Exzell Pharma Inc.
Glaxosmithkline Plc
Johnson & Johnson
Novartis AG
Pfizer Inc.
Reckitt Benckiser Group Plc
Sanofi S.A.
Sun Pharmaceutical Industries Limited
Topical Biomedics Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

31 August 2023: Johnson & Johnson launched new pain solution, the topical Tylenol(R) Precise(TM) Pain Relieving Cream. Tylenol Precise fits active lifestyles with a rapid-absorbing formula, fragrance-free and fresh scent options for discreet use, and a uniquely designed rollerball for hands-free, no-mess application leaving skin clear of sticky residues.
23 June 2023: Exzell Pharma Inc., the brand house of Myoflex, announced a multiyear partnership with Pickleball Canada, the National Sport Organization for pickleball. Myoflex has been used by active people of all ages and abilities for muscle aches, strains, and pains.
24 February 2021: Reckitt Benckiser Group Plc announced that it has entered into a definitive agreement to acquire the Biofreeze brand from Performance Health. The acquisition represents a unique and exciting opportunity to unlock value through RB's expertise, global operating footprint, and infrastructure. Biofreeze is a perfect fit with RB's Health platform and deepens RB's presence within the broader pain category.

Key Questions Answered in This Report:

How has the global topical pain relief market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global topical pain relief market?
What is the impact of each driver, restraint, and opportunity on the global topical pain relief market?
What are the key regional markets?
Which countries represent the most attractive topical pain relief market?
What is the breakup of the market based on the therapeutic class?
Which is the most attractive therapeutic class in the topical pain relief market?
What is the breakup of the market based on the formulation?
Which is the most attractive formulation in the topical pain relief market?
What is the breakup of the market based on the type?
Which is the most attractive type in the topical pain relief market?
What is the breakup of the market based on the distribution channel?
Which is the most attractive distribution channel in the topical pain relief market?
What is the competitive structure of the market?
Who are the key players/companies in the global topical pain relief market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Topical Pain Relief Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Therapeutic Class

6.1 Non-Opioids
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Opioids
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Formulation

7.1 Cream
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Gel
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Spray
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Patch
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast

8 Market Breakup by Type

8.1 Prescription Pain Relief
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Over the Counter (OTC) Pain Relief
- 8.2.1 Market Trends
- 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Pharmacy and Drug Stores
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Stores
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Stores
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Advacare Pharma
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Exzell Pharma Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Glaxosmithkline Plc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Johnson & Johnson
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 Novartis AG
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 Pfizer Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Reckitt Benckiser Group Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Sanofi S.A.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Sun Pharmaceutical Industries Limited
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Topical Biomedics Inc.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Topical Pain Relief Market: Major Drivers and Challenges
Figure 2: Global: Topical Pain Relief Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Topical Pain Relief Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Topical Pain Relief Market: Breakup by Therapeutic Class (in %), 2023
Figure 5: Global: Topical Pain Relief Market: Breakup by Formulation (in %), 2023
Figure 6: Global: Topical Pain Relief Market: Breakup by Type (in %), 2023
Figure 7: Global: Topical Pain Relief Market: Breakup by Distribution Channel (in %), 2023
Figure 8: Global: Topical Pain Relief Market: Breakup by Region (in %), 2023
Figure 9: Global: Topical Pain Relief (Non-Opioids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Topical Pain Relief (Non-Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Topical Pain Relief (Opioids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Topical Pain Relief (Opioids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Topical Pain Relief (Cream) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Topical Pain Relief (Cream) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Topical Pain Relief (Gel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Topical Pain Relief (Gel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Topical Pain Relief (Spray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Topical Pain Relief (Spray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Topical Pain Relief (Patch) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Topical Pain Relief (Patch) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Topical Pain Relief (Other Formulations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Topical Pain Relief (Other Formulations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Topical Pain Relief (Prescription Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Topical Pain Relief (Prescription Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Topical Pain Relief (Over the Counter (OTC) Pain Relief) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Topical Pain Relief (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Topical Pain Relief (Retail Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Topical Pain Relief (Retail Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Topical Pain Relief (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Topical Pain Relief (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: North America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: North America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: United States: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: United States: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Canada: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Canada: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Asia-Pacific: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Asia-Pacific: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: China: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: China: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Japan: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Japan: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: India: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: India: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: South Korea: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: South Korea: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Australia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Australia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Indonesia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Indonesia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Europe: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Germany: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Germany: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: France: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: France: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: United Kingdom: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: United Kingdom: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Italy: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Italy: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Spain: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Spain: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Russia: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Russia: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Latin America: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Latin America: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Brazil: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Brazil: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Mexico: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Mexico: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Others: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Others: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Middle East and Africa: Topical Pain Relief Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Middle East and Africa: Topical Pain Relief Market: Breakup by Country (in %), 2023
Figure 81: Middle East and Africa: Topical Pain Relief Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Global: Topical Pain Relief Industry: SWOT Analysis
Figure 83: Global: Topical Pain Relief Industry: Value Chain Analysis
Figure 84: Global: Topical Pain Relief Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Topical Pain Relief Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Topical Pain Relief Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
Table 3: Global: Topical Pain Relief Market Forecast: Breakup by Formulation (in Million US$), 2024-2032
Table 4: Global: Topical Pain Relief Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 5: Global: Topical Pain Relief Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 6: Global: Topical Pain Relief Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Topical Pain Relief Market: Competitive Structure
Table 8: Global: Topical Pain Relief Market: Key Players

02-2729-4219

+886-2-2729-4219